Purchases and Sales Made in Q4 2023 in Adaptive Biotechnologies Corp (ADPT)
This table provides information about the institutional ownership of Adaptive Biotechnologies Corp (ADPT) during Q4 2023. The information is specifically focused on institutions that hold shares of Adaptive Biotechnologies Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2024
Q4 2023
|
Ci Private Wealth, LLC
Miami, FL |
SELL
|
- |
-47.1K- 36.22% |
$163K - $251K
|
82.9K
$643K
|
|
|
Feb 12, 2024
Q4 2023
|
Blair William & CO
Chicago, IL |
SELL
|
- |
-49K- 76.99% |
$170K - $261K
|
14.6K
$114K
|
|
|
Feb 09, 2024
Q4 2023
|
Pier 88 Investment Partners LLC
San Francisco, CA |
SELL
|
- |
-51.7K- 67.59% |
$179K - $276K
|
24.8K
$192K
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-56.6K- 50.37% |
$196K - $302K
|
55.8K
$432K
|
|
|
Jan 30, 2024
Q4 2023
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-59.3K- 0.9% |
$205K - $316K
|
6.51M
$50.5M
|
|
|
Feb 08, 2024
Q4 2023
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-59.3K- 0.9% |
$205K - $316K
|
6.51M
$50.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-60.3K- 14.16% |
$209K - $322K
|
366K
$2.83M
|
|
|
Jan 26, 2024
Q4 2023
|
Peregrine Capital Management LLC
|
SELL
|
- |
-64.3K- 14.62% |
$223K - $343K
|
376K
$2.91M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-89.5K- 68.2% |
$310K - $477K
|
41.7K
$324K
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-103K- 12.01% |
$357K - $550K
|
756K
$5.86M
|
|
|
Feb 14, 2024
Q4 2023
|
Putnam Investments LLC
Boston, MA |
SELL
|
- |
-114K- 58.86% |
$394K - $607K
|
79.6K
$617K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-141K- 98.01% |
$488K - $752K
|
2.87K
$22.3K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-153K- 6.68% |
$529K - $815K
|
2.14M
$16.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-157K- 48.38% |
$543K - $837K
|
167K
$1.3M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-164K- 1.41% |
$566K - $872K
|
11.4M
$88.5M
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-173K- 12.46% |
$597K - $920K
|
1.21M
$9.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-194K- 79.05% |
$671K - $1.03M
|
51.4K
$398K
|
|
|
Feb 09, 2024
Q4 2023
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-274K- 64.65% |
$947K - $1.46M
|
150K
$1.16M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-606K- 68.24% |
$2.1M - $3.23M
|
282K
$2.19M
|
|
|
Feb 14, 2024
Q4 2023
|
Blue Water Life Science Advisors, LP
Larkspur, CA |
SELL
|
- |
-690K- 29.02% |
$2.39M - $3.68M
|
1.69M
$13.1M
|
|
|
Feb 07, 2024
Q4 2023
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-755K- 60.53% |
$2.61M - $4.02M
|
492K
$3.81M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-893K- 52.62% |
$3.09M - $4.76M
|
804K
$6.23M
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.99M- 34.85% |
$6.89M - $10.6M
|
3.72M
$28.8M
|